Updated Jul 16, 2026
Patel Sushil has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $1.74M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 881 | $192.61 | $170K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 541 | $191.87 | $104K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 600 | $190.54 | $114K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 100 | $188.57 | $19K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 300 | $187.83 | $56K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 858 | $186.92 | $160K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 1.1K | $185.90 | $204K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 900 | $184.59 | $166K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | S — Open-market sale | 300 | $183.17 | $55K |
| 2026-07-01 | RVMD | Revolution Medicines, Inc. | M — Option exercise | 3.0K | $37.54 | $111K |
| 2026-06-23 | RVMD | Revolution Medicines, Inc. | A — Grant or award | 1.2K | $0.00 | |
| 2026-05-20 | REPL | Replimune Group, Inc. | S — Open-market sale | 37.3K | $5.08 | $190K |
| 2026-04-08 | REPL | Replimune Group, Inc. | A — Grant or award | 251.2K | $0.00 | |
| 2025-12-04 | REPL | Replimune Group, Inc. | S — Open-market sale [10b5-1] | 10.0K | $11.13 | $111K |
| 2024-12-18 | REPL | Replimune Group, Inc. | S — Open-market sale [10b5-1] | 10.0K | $12.42 | $124K |
| 2024-11-04 | RVMD | Revolution Medicines, Inc. | S — Open-market sale [10b5-1] | 5.0K | $54.14 | $271K |
| 2024-11-04 | RVMD | Revolution Medicines, Inc. | M — Option exercise [10b5-1] | 5.0K | $24.84 | $124K |
Patel Sushil is a corporate insider — currently tracked as Insider of Revolution Medicines, Inc. (RVMD). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 13 open-market sales ($1.74M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Patel Sushil profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.